APSR2026-852

 
Late-Breaking
Submitted
Oral Presentation
AO30-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1221248-46903-APSR-852_440281.pptx
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Nik Nur Amirah Nik Abeed * Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Nurul Aimi Abd Ghani - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Kezreen Kaur Dhaliwal - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
Syazatul Syakirin Sirol Aflah - Institut Perubatan Respiratori Respiratori Kuala Lumpur Malaysia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Nik Nur Amirah
Nik Abeed
nikamirahabeed@gmail.com
+60199102324
31-40
Malaysia
Original Research
Phenotyping Autoimmune-Dominant ILD: A Correlative Study of Radiographic Patterns and Serological Integration
Maximum 25 words
Abstract Content
Autoimmune-dominant interstitial lung disease (ILD) frequently presents as a lung-first phenotype, diagnosed by pulmonologists without systemic symptoms. Delaying management until formal connective tissue disease (CTD) criteria putting the risk of irreversible lung progression. High resolution computed tomography (HRCT) patterns and positive serology provide critical "autoimmune clues." This study aims to characterize similarities in HRCT morphologies and serological profiles between autoimmune-dominant and established CTD-ILD.
A retrospective study of 140 ILD patients was conducted at Institut Perubatan Respiratori (2017–2025). Patients were categorized into autoimmune-dominant-ILD (no overt CTD features) and CTD-ILD groups. Demographic data, autoantibody profiles, and HRCT patterns were analysed.
The cohort was predominantly female (70.7%) and non-smokers (85%) with a mean age of 58 years. Autoimmune-dominant ILD accounted for 52.9% (n=74) of cases, while 47.1% (n=66) has established CTD. Seropositive autoantibodies was high in both groups, which account 85.1% in autoimmune dominant ILD and 98.5% in CTD-ILD. Non-specific interstitial pneumonia (NSIP) pattern was the most prevalent pattern in both autoimmune-dominant (27.1%) and CTD-ILD (30.3%). Autoimmune-dominant cases showed higher NSIP-organising pneumonia (OP) pattern (20.3% vs. 9.1%), whereas CTD-ILD exhibited a greater burden of UIP and probable UIP (34.9% combined. Significant correlations emerged between HRCT patterns and autoantibody profiles. In autoimmune-dominant ILD, we observed anti-Ro/SSA associated with indeterminate UIP (p=0.028), anti-Scl70 with fibrotic NSIP (p=0.038), and myositis antibodies with OP patterns (p=0.032). In CTD-ILD, stronger correlations were observed between anti-Scl70 and indeterminate UIP (p=0.001) and myositis antibodies with fibrotic OP (p=0.001).
The findings conclude a radiological-serological convergence which empowers the pulmonologists to treat autoimmune-dominant ILD as a primary lung phenotype. Integrating HRCT and serology enables early, independent intervention, preventing irreversible progression without waiting formal CTD criteria. This proactive strategy ensures timely lung-directed therapy, while rheumatologist referral is prioritized for comprehensive extrapulmonary assessment.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
autoimmune-dominant interstitial lung disease, connective tissue disease interstitial lung disease (CTD-ILD), high resolution computed tomography (HRCT)
maximum 3 keywords and no abbreviations, separated by commas
nil
313